Perspectiva global sobre los datos de tratamientos emergentes con inhibidores de TQB para LLC y LCM en recidiva/refractarios en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Une perspective globale sur les données émergentes relatives à la thérapie par inhibiteurs BTK chez les patients atteints de LLC ou du LCM récidivant/réfractaire en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL in 2022

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Einblicke in neue Daten zu BTK-Inhibitoren bei CLL und MCL aus der Pan Pacific Lymphoma Conference 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Approfondimenti sui nuovi dati relativi agli inibitori di BTK per la CLL e lMCL emersi dalla Conferenza Pan Pacific Lymphoma del 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Aperçu des nouvelles données sur les inhibiteurs de la BTK pour le traitement de la LLC et du LCM lors de la Pan Pacific Lymphoma Conference de 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Insights on New Data With BTK Inhibitors for CLL and MCL From the 2022 Pan Pacific Lymphoma Conference

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
FAQs: Incorporating Novel and Emerging Treatment Combinations Into the Management of Aggressive B-Cell Lymphomas

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Biomarkers for Risk Stratification and Treatment Selection for Patients With MCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast Pearls: Advances Across B Cell Lymphomas

Content Format:

PDF

Credit Type:

--

Credits:

--
A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
ExpressPoints: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
New Advances in Diffuse Large B-Cell Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Novel Approaches to the Treatment of EBV-Associated Post-Transplant Lymphoproliferative Disorders

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How I Treat Patients With EBV-Associated Posttransplant Lymphoproliferative Disease

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
How I Sequence Treatment for Patients With Diffuse Large B-Cell Lymphoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: MCL Expert Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Cancer Conversations™ Experts Discuss Evolving Treatment Paradigms and Ongoing Clinical Trials in Mantle Cell Lymphoma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
ExpressPoints:Cancer Conversations™: Experts Discuss Evolving Treatment Paradigms and Ongoing Clinical Trials in Mantle Cell Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cancer Conversations™: Experts Discuss Evolving Treatment Paradigms and Ongoing Clinical Trials in Mantle Cell Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Insights sobre novos dados com inibidores de BTK para LLC e LCM da edição 2022 da Conferência Pan-Pacífico sobre Linfomas (Pan Pacific Lymphoma Conference)

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Conclusiones sobre los nuevos datos relativos a los inhibidores de la TQB para LLC y LCM de la Conferencia del Pacífico sobre el Linfoma de 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--